Seasoned leadership team poised to deliver clinical and commercial success
Over 35 years in commercial and senior leadership roles in life-sciences with an established track record in funding and growing companies
Professor of Hepatology and Head of the Liver Failure Group at University College London. Key opinion leader in advanced liver disease and ACLF, extensively published
Experienced research & clinical development leader in biotech and big pharma, with a record of leading teams through to regulatory success
Julie is a seasoned CFO with over two decades of experience in executive finance roles, where she has supported numerous equity and debt raisings
Drug development scientist with expertise in strategic design and analysis of clinical trials, with a specialty in liver disease
Clinical and regulatory specialist with experience advising big pharma and start-up biotechs
Strategic communicator with more than 25 years of experience in the life-science industry, covering investor relations, communication, business strategy and healthcare investment
Expert in scaling biotech startups and business engineering leveraging technical expertise and business acumen for strategic growth
More than 35 years clinical operations experience including overseeing phase 2/3 studies and securing funding in research innovation
Entrepreneur and former CSO with expertise in regulatory strategy, licensing and business development, iand new and orphan drug product approvals
A seasoned biopharmaceutical entrepreneur and leader with over 25 years of experience across translational research, business strategy, global development, and project leadership
Healthcare innovator and hedge fund strategist with background in economics/finance and biomedical science
Therapeutic for acute-on-chronic liver failure
Extracorporeal liver support for acute-on-chronic liver failure
Advanced microbiome therapeutic to restore gut health
Treatment and prevention of recurrence of hepatic encephalopathy
